Drug distribution giant AmerisourceBergen fell two spots on the Fortune 500 from last year. Like its large rivals in the business, the company continues to wrestle with lawsuits regarding its alleged role in the opioid crisis while enduring criticism from shareholders. Still, the company increased its revenue by 12.7%, to $214 billion for the fiscal year ended September 2021. AmerisourceBergen added more than 18,000 new employees and unveiled a new global headquarters in Conshohocken, Pa.
Lists ranking AmerisourceBergen
World’s Most Admired Companies - 2022Just as it dominates our economy, Big Tech now dom...READ MOREview in list
Latest news for AmerisourceBergen
- HealthJohnson & Johnson, drug distributors reach $26 billion settlement with states over opioidsJuly 21, 2021 7:25 PM UTC
- Health4 Drug Giants Reach $260 Million Settlement in Ohio Opioid Case. What Happens Next?October 21, 2019 5:27 PM UTC
- LeadershipAmerisource CEO Doubts Amazon will be a “Significant Force” in Drug IndustryAugust 2, 2018 1:54 PM UTC
- HealthWhat Is AmerisourceBergen and Why Does Walgreens Want to Buy It?February 13, 2018 11:26 AM UTC